ADMA Biologics receives FDA approval to expand ASCENIV label for pediatric use

May 4, 2026 7:00 AM

ADMA Biologics Inc. (NASDAQ: ADMA) announced that the U.S. Food and Drug Administration has approved the company's supplemental Biologics License ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found